Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Other Operating Expenses (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of Other Operating Expenses data on record, last reported at $7.5 million in Q3 2025.

  • For Q3 2025, Other Operating Expenses fell 12.07% year-over-year to $7.5 million; the TTM value through Sep 2025 reached $24.8 million, down 11.6%, while the annual FY2023 figure was $10.0 million, 15284.62% up from the prior year.
  • Other Operating Expenses reached $7.5 million in Q3 2025 per GOSS's latest filing, down from $8.7 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $10.0 million in Q4 2023 and bottomed at $15000.0 in Q2 2022.
  • Average Other Operating Expenses over 4 years is $4.4 million, with a median of $3.7 million recorded in 2022.
  • The widest YoY moves for Other Operating Expenses: up 66566.67% in 2023, down 25.0% in 2023.
  • A 4-year view of Other Operating Expenses shows it stood at $15000.0 in 2022, then skyrocketed by 66566.67% to $10.0 million in 2023, then dropped by 14.98% to $8.5 million in 2024, then fell by 12.07% to $7.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Operating Expenses were $7.5 million in Q3 2025, $8.7 million in Q2 2025, and $8.7 million in Q1 2025.